首页> 外文OA文献 >A new convenient synthetic method and preliminary pharmacological characterization of triazinediones as prokineticin receptor antagonists
【2h】

A new convenient synthetic method and preliminary pharmacological characterization of triazinediones as prokineticin receptor antagonists

机译:三嗪二酮作为促动素受体拮抗剂的一种方便的新合成方法和初步药理学表征

摘要

A new efficient synthetic method to obtain prokineticin receptor antagonists based on the triazinedione scaffold is described. In this procedure the overall yield improves from 13% to about 54%, essentially for two factors: 1) N-(chlorocarbonyl) isocyanate is no more used, it represents the yield limiting step with an average yield not exceeding 30%. 2) The Mitsunobu reaction is not involved in the new synthetic scheme avoiding the use of time and solvent consuming column chromatography. All synthesized triazinediones were preliminary pharmacologically screened in vivo for their ability to reduce the Bv8-induced thermal hyperalgesia. In this assay all compounds displayed EC50 values in the picomolar–subpicomolar range, some triazinediones containing a 4-halogen substituted benzyl group in position 5 showed the best activity. The analogues containing a 4-fluorine atom (PC-7) and a 4-bromobenzyl group (PC-25) resulted 10 times more potent than the reference PC-1 that bears a 4-ethylbenzyl group. While the 4-trifluoromethylbenzyl substituted analog (PC-27) was 100 times more potent as compared to PC1.
机译:描述了一种新的有效的合成方法来获得基于三嗪二酮支架的促动力素受体拮抗剂。在该程序中,总的收率从13%提高到约54%,主要是出于两个因素:1)不再使用N-(氯羰基)异氰酸酯,它代表了收率限制步骤,平均收率不超过30%。 2)Mitsunobu反应不参与新的合成方案,从而避免了使用时间和消耗溶剂的柱色谱法。所有合成的三嗪二酮均具有降低Bv8诱导的热痛觉过敏的能力,并在体内进行了初步药理筛选。在该分析中,所有化合物的EC50值均在皮摩尔至亚皮摩尔范围内,某些在5位上含4-卤素取代的苄基的三嗪二酮显示出最佳活性。含有4-氟原子(PC-7)和4-溴苄基(PC-25)的类似物比具有4-乙基苄基的参比PC-1的效力强10倍。而4-三氟甲基苄基取代的类似物(PC-27)的效力是PC1的100倍。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号